Hydramine and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Viracept (nelfinavir mesylate). Common drug interactions include emotional distress among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Viracept. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

On Jul, 29, 2026

25 people who take Hydramine and Viracept together, and have interactions are studied.

Hydramine and Viracept drug interactions.

What are the common drug interactions of Hydramine and Viracept, by gender? *:

female:

Emotional distress
Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Ankle fracture
Anxiety
Depression
Bone density decreased
Chronic kidney disease
Fibula fracture
Foot fracture

male:

Emotional distress
Pain
Bone density decreased
Renal failure (kidney dysfunction)
Gait disturbance
Mobility decreased (ability to move is reduced)
Osteoporosis (bones weak and more likely to break)
Post-traumatic stress disorder
Rash erythematous (redness of the skin)
Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

What are the common drug interactions of Hydramine and Viracept, by age (0-1 to 60+)? *:

0-1:

Death
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Rash erythematous (redness of the skin)
Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Folliculitis (infection of hair root)
Headache (pain in head)
Lip ulceration (ulcer of lip)
Mouth ulceration (mouth ulcers)
Photophobia (extreme sensitivity to light)
Rash papular (redness with papule)
Skin nodule (slightly elevated lesions on or in the skin)
Swelling

40-49:

Back pain
Chronic kidney disease
Gait disturbance
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Pain in extremity
Renal failure (kidney dysfunction)
Hepatic steatosis (fatty liver disease)
Pruritus (severe itching of the skin)
Rash

50-59:

Emotional distress
Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Chronic kidney disease
Fibula fracture
Mobility decreased (ability to move is reduced)
Osteoporosis (bones weak and more likely to break)
Renal impairment (severely reduced kidney function)

60+:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Back pain
Gamma-glutamyltransferase increased
Horner's syndrome (horner syndrome is a disorder that affects the eye and surrounding tissues on one side of the face and results from paralysis of certain nerves)
Renal failure (kidney dysfunction)
Obesity (having too much body fat)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Weight increased
Bone density decreased
Chronic kidney disease

What are the existing conditions these people have? *

Hypersensitivity: 5 people, 20.00%
Depression: 5 people, 20.00%
Pain: 4 people, 16.00%
High Blood Pressure: 4 people, 16.00%
High Blood Cholesterol: 4 people, 16.00%
Diabetes: 4 people, 16.00%
Cardiac Disorder: 4 people, 16.00%
Viral Infection: 3 people, 12.00%
Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 12.00%
Indigestion: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously